Clinical backgrounds associated with discrepancy between subjective and objective assessments of medication adherence in Japanese type 2 diabetic patients

被引:4
|
作者
Takahara M. [1 ,2 ]
Shiraiwa T. [3 ]
Ogawa N. [4 ]
Katakami N. [2 ]
Matsuoka T.-A. [2 ]
Shimomura I. [2 ]
机构
[1] Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita City, 565-0871, Osaka
[2] Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita City, 565-0871, Osaka
[3] Shiraiwa Medical Clinic, Shiraiwa Medical Clinic, 4-10-24 Hozenji, Kashiwara City, 582-0005, Osaka
[4] Smile Pharmacy, 4-10-25 Hozenji, Kashiwara City, 582-0005, Osaka
关键词
Discrepancy; Medication adherence; Oral agents; Pill counts; Self-report;
D O I
10.1007/s13340-016-0265-z
中图分类号
学科分类号
摘要
Although medication adherence can be easily assessed by self-reports in clinical practice, accuracy is sometimes questionable. To make full use of self-reports on medication adherence in clinical practice, understanding the discrepancy between subjectively and objectively assessed adherence is important. The aim of this study was to investigate which clinical characteristics would be associated with such discrepancy regarding adherence to oral antidiabetic drugs (OADs) in type 2 diabetic patients. Our study assessed 406 Japanese type 2 diabetic outpatients treated with OADs. Medication adherence to OADs was evaluated in percentage, both subjectively by self-report and objectively by pill counts on the same day. We developed a common regression model by extending the generalized linear mixed model and statistically detected the difference in the impact of clinical characteristics between the two measures. Subjectively measured adherence was higher than objectively measured adherence, showing a 1.6-fold difference in odds (p < 0.001). Male gender, older age, longer diabetic duration, and taking more than two OADs daily were independently associated with the overrating of medication adherence by self-report compared with the objectively measured adherence. On the other hand, higher glycocylated hemoglobin (HbA1c) levels, taking medication before meals, and taking medication outside the home were independently associated with underrating medication adherence by self-report. In conclusion, this study demonstrated clinical characteristics associated with overrating and underrating of medication adherence by self-report in Japanese type 2 diabetic patients treated with OADs. © 2016, The Japan Diabetes Society.
引用
收藏
页码:398 / 403
页数:5
相关论文
共 50 条
  • [41] Associations Between Habit and Its Determinants with Medication Adherence in Chilean Patients with Type 2 Diabetes Mellitus
    Schleef, Jorge
    Ortiz, Manuel S.
    [J]. BEHAVIORAL MEDICINE, 2024,
  • [42] Effect of shared care program with structured assessments on clinical outcomes in Chinese type 2 diabetic patients
    Kong, APS
    So, WY
    Wong, R
    Loo, KM
    Lau, MSW
    Chan, WB
    Ozaki, R
    Ma, RCW
    Chow, CC
    Tong, PCY
    Cockram, CS
    Chan, JCN
    [J]. DIABETES, 2005, 54 : A614 - A614
  • [43] Clinical Characteristics Associated with the Development of Diabetic Ketoacidosis in Patients with Type 2 Diabetes
    Masuda, Seizaburo
    Ota, Kazuki
    Okazaki, Rei
    Ishii, Ryoko
    Cho, Keiho
    Hiramatsu, Yuki
    Adachi, Yuko
    Koseki, Sayo
    Ueda, Eri
    Minami, Isao
    Yamada, Tetsuya
    Watanabe, Takayuki
    [J]. INTERNAL MEDICINE, 2022, 61 (08) : 1125 - 1132
  • [44] Relationship between self reported medication adherence and knowledge of clinical cardiovascular and A1c goals and values in diabetic patients
    Nicol, PR
    Lawrence, DB
    Ter Riet, LR
    [J]. DIABETES, 2005, 54 : A228 - A228
  • [45] Genes associated with obesity, weight gain or insulin requirement in Japanese type 2 diabetic patients
    Nishi, M
    Sasahara, M
    Yabiku, K
    Furuta, H
    Hanabusa, T
    Sasaki, H
    Sanke, T
    Nanjo, K
    [J]. DIABETES, 2003, 52 : A559 - A559
  • [46] Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients
    Anan, Futoshi
    Masaki, Takayuki
    Ito, Yuji
    Eto, Takahiko
    Umeno, Yoshikazu
    Eshima, Nobuoki
    Saikawa, Tetsunori
    Yoshimatsu, Hironobu
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (03): : 314 - 319
  • [47] Visfatin is not associated with visceral obesity itself, but with glucose metabolism in Japanese type 2 diabetic patients
    Watarai, Atsuko
    Nakashima, Eitaro
    Naruse, Keiko
    Kobayashi, Yasuko
    Nakae, Mika
    Kimura, Nachi
    Nakamura, Nobuhisa
    Tosaki, Takabiro
    Oiso, Yutaka
    Nakamura, Jiro
    [J]. DIABETES, 2006, 55 : A597 - A598
  • [48] Clinical worth of adiponectin levels in obesity and glycemic control of Japanese type 2 diabetic patients
    Nonogaki, K
    Kumano, H
    Ootsuka, Y
    Takeuchi, A
    Nonogaki, N
    [J]. DIABETES CARE, 2003, 26 (11) : 3198 - 3198
  • [49] USE OF ANTI-DIABETIC MEDICATION IS NOT ASSOCIATED WITH CANCER RISK IN CHINESE PATIENTS WITH TYPE 2 DIABETES
    He, X.
    Shi, L.
    Wu, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S19 - S20
  • [50] Factors associated with medication non-adherence in patients with type 2 diabetes mellitus: The first Algerian survey
    Achouri, M. Y.
    Mammeri, M.
    Sehanine, Y.
    Selka, M. A.
    Ghomari, W. I.
    Lahmer, A.
    Habib, M. Hadj
    [J]. ANNALES PHARMACEUTIQUES FRANCAISES, 2019, 77 (06): : 506 - 515